La imperiosa necesidad de reconstruir el sistema valorativo de los aportes científicos
DOI:
https://doi.org/10.17533/udea.rfnsp.e344778Downloads
References
Ioannidis JP. Why most published research findings are false. PLOS Medicine. 2005;2(8):0696-0701. DOI: https://doi.org/10.1371/journal.pmed.0020124
Begley CG, Ioannidis JP. Reproducibility in science: Improving the standard for basic and preclinical research. Circulation Research.2015;116(1):116-26. DOI: https://doi.org/10.1161/CIRCRESAHA.114.303819
Baker M. 1,500 scientists lift the lid on reproducibility. Nature. 2016;533:452-4.
Silva LC. Crisis en la calidad de la ciencia médica: el papel del arbitraje en el nuevo desorden editorial. iris. Informação, Memória e Tecnologia.2018;4(1):8-21.
Gøtzsche P. Deadly medicines and organized crime. How big pharma has corrupted healthcare. New York: Radcliffe, 2013.
Budapest Open Access Initiative. Ten years on from the Budapest Open Access Initiative: Setting the default to open. Budapest Open Access Initiative; 2012. Disponible en: http://www.budapestopenaccessinitiative.org/boai-10-recommendations
Nosek BA, Bar-Anan Y. Scientific communication is changing and scientists should lead the way. Psychological Inquiry. 2012;23(3):308-14.
Bosman, J. Nine reasons why impact factors fail and using them may harm science. I&M / I&O 2.0; 2013. Disponible en: https://im2punt0.wordpress.com/2013/11/03/nine-reasons-why-impact-factors-fail-and-using-them-may-harm-science/
Parra S. Auge, caída y auge del remdesivir, el “esperanzador” antiviral para combatir el COVID-19; 2020. Disponible en: https://www.xataka.com/medicina-y-salud/auge-caida-auge-remdesivir-esperanzador-antiviral-para-combatir-covid-19
Gautret P, Lagier JC, Parola P, et al. Hydroxychloroquine and azithromycin as a treatment of covid-19: Results of an open-label non-randomized clinical trial. Int J Antimicrob Agents; 2020:56(1): 105949. doi:https://doi.org/10.1016/j.ijantimicag.2020.105949
Baker P, Rogers K, et al. Trump’s aggressive advocacy of malaria drug for treating coronavirus divides medical community. The New York Times. 2020 abr. 6.
Mehra MR, Desai SS, Ruschitzka F, Patel AN. Retracted: Hydroxychloroquine or chloroquine with or without a macrolide for treatment of covid-19: A multinational registry analysis. The Lancet, 2020(mayo 22):1-10. DOI: https://doi.org/10.1016/S0140-6736(20)31180-6
WHO Solidarity Trial Consortium. Repurposed antiviral drugs for COVID-19 –interim who solidarity trial results. 2020; oct. 15. Disponible en: https://bit.ly/3nYAPhC
Published
How to Cite
Issue
Section
License
The contents of the articles are the responsibility of the authors
The editorial committee has editorial independence from the National School of Public Health "Héctor Abad Gómez" of the University of Antioquia.
The editorial committee is not responsible for aspects related to copying, plagiarism or fraud that may appear in the articles published in it.
When you are going to reproduce and disclose photographs or personal data in printed or digital format, informed consent is required. Therefore, this requirement is required of the author at the time of receipt of the manuscript.
Authors are responsible for obtaining the necessary permissions to reproduce any material protected by reproduction rights.
The authors preserve the moral rights and assign the economic rights that will correspond to the University of Antioquia, to publish it, distribute electronic copies, include them in indexing services, directories or national and international databases in Open Access, under the Creative Commons Attribution license -Not Commercial-Share Equal 4.0 International Commercial (CC BY-NC-SA) which allows others to distribute, remix, retouch, and create from the work in a non-commercial way, as long as the respective credit and license are granted. new creations under the same conditions.
The authors will sign the declaration of transfer of economic rights to the University of Antioquia, after the acceptance of the manuscript.
The editorial committee reserves the right to reject the articles whose authors do not offer satisfactory explanations about the contribution of each author, to meet the criteria of authorship in the submission letter. All authors must meet the four criteria of authorship according to ICMJE: "a) .- That there is a substantial contribution to the conception or design of the article or to the acquisition, analysis or interpretation of the data. b) That they have participated in the design of the research work or in the critical review of its intellectual content. c) .- That has been intervened in the approval of the final version that will be published.d). That they have the capacity to respond to all aspects of the article in order to ensure that issues related to the accuracy or integrity of any part of the work are adequately investigated and resolved. "
-- 
--
